Orchard Therapeutics Provides Business Update and Reports
OTL-200 pre-BLA meeting granted for second quarter of 2023 following productive clinical Type B meeting with the U.S. Food and Drug Administration (FDA) ...
Source: globenewswire.com
Page 30 - Pharming Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Pharming Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Pharming Group Today - Breaking & Trending Today
Pharming Group N.V.: Notice of Full Year 2022 financial results
LEIDEN, Netherlands, Feb. 28, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM) (Nasdaq: PHAR) confirms it will announce its unaudited Full Year
Source: finanznachrichten.de
Notice of Full Year 2022 financial results
/PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM) (Nasdaq: PHAR) confirms it will announce its unaudited Full Year...
Source: prnewswire.com
Pharming Group N.V.: Pharming announces first patient enrolled in pediatric clinical trial of leniolisib
The multinational Phase III study is evaluating leniolisib tablets in children aged 4 to 11 years with APDS, a rare primary immunodeficiency LEIDEN, Netherlands, Feb. 21, 2023 /PRNewswire/
Source: finanznachrichten.de
Pharming announces first patient enrolled in pediatric clinical trial of leniolisib
/PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM)/(Nasdaq: PHAR) announces that the first patient has been enrolled...
Source: prnewswire.com